These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6143826)
21. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Doxey JC; Roach AG; Smith CF Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640 [TBL] [Abstract][Full Text] [Related]
22. Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons. Freedman JE; Aghajanian GK Eur J Pharmacol; 1984 Oct; 105(3-4):265-72. PubMed ID: 6150858 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II). Khouili M; Guillaumet G; Coudert G; Pujol MD Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140 [TBL] [Abstract][Full Text] [Related]
24. Differential blockade of pre- and postsynaptic alpha-adrenoceptors by the 2-R and 2-S enantiomers of WB4101. Mottram DR J Pharm Pharmacol; 1981 Dec; 33(12):767-71. PubMed ID: 6121847 [TBL] [Abstract][Full Text] [Related]
25. [Synthesis and alpha-adrenolytic activities of 2-(1,4-benzodioxan-2-yl- methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives]. Glusa E; GrĂ¼ner H; Hagen A; Lohmann D; Foken H Pharmazie; 1990 Jun; 45(6):408-10. PubMed ID: 1976262 [TBL] [Abstract][Full Text] [Related]
26. Further studies on receptor interaction for the alpha-antagonist WB 4101. Kapur H; Green PN; Mottram DR J Pharm Pharmacol; 1979 Mar; 31(3):188-9. PubMed ID: 34700 [No Abstract] [Full Text] [Related]
27. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist. Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Leonardi A; Taddei C; Melchiorre C J Med Chem; 1996 May; 39(11):2253-8. PubMed ID: 8667368 [TBL] [Abstract][Full Text] [Related]
28. 3-Phenyl analogues of 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]-methyl]-1,4-benzodioxan (WB 4101) as highly selective alpha 1-adrenoceptor antagonists. Quaglia W; Pigini M; Giannella M; Melchiorre C J Med Chem; 1990 Nov; 33(11):2946-8. PubMed ID: 1977906 [No Abstract] [Full Text] [Related]
29. Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells. Langin D; Paris H; Dauzats M; Lafontan M Eur J Pharmacol; 1990 Apr; 188(4-5):261-72. PubMed ID: 1973120 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and alpha-adrenoreceptor blocking properties of phenoxybenzamine-related (2-chloroethyl)-(2,3-dihydrobenzo[1,4]dioxin- 2-ylmethyl)-(2-phenoxyethyl) amines. GiardinĂ D; Crucianelli M; Marucci G; Paparelli F; Melchiorre C Bioorg Med Chem; 1995 Jan; 3(1):85-94. PubMed ID: 8612050 [TBL] [Abstract][Full Text] [Related]
31. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors. Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291 [TBL] [Abstract][Full Text] [Related]
32. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens. Hicks PE; Langer SZ; Macrae AD Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967 [TBL] [Abstract][Full Text] [Related]
33. [Alpha-adrenoblocking activity of a newly synthesized derivative of 1,4-benzodioxane]. Staneva D; Spasov V; Ivanov D Eksp Med Morfol; 1984; 23(2):87-91. PubMed ID: 6147242 [No Abstract] [Full Text] [Related]
34. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes. Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553 [TBL] [Abstract][Full Text] [Related]
35. Electrophysiological demonstration of both alpha 2-agonist and antagonist properties of RX 781094. Goldstein JM; Knobloch LC; Malick JB Eur J Pharmacol; 1983 Jul; 91(1):101-5. PubMed ID: 6137390 [TBL] [Abstract][Full Text] [Related]
36. The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in man. Muir NC; Doxey JC; Havler ME; Clifford JM J Pharmacol Methods; 1987 Sep; 18(2):95-102. PubMed ID: 2887703 [TBL] [Abstract][Full Text] [Related]
37. Effects of alpha-adrenoceptor agonists and antagonists and of antidepressant drugs on pre- and postsynaptic alpha-adrenoceptors. Brown J; Doxey JC; Handley S Eur J Pharmacol; 1980 Oct; 67(1):33-40. PubMed ID: 6106552 [TBL] [Abstract][Full Text] [Related]
38. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro. Perrone MH; Hamel LT; Ferrari RA; Haubrich DR J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637 [TBL] [Abstract][Full Text] [Related]
39. Alpha-blocking properties of idazoxan (170150 or RX 781094) and its stereoisomers: applications to bronchomotricity. Floch A; Advenier C J Pharmacol; 1985; 16(3):291-7. PubMed ID: 2866275 [TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships for 2-substituted imidazoles as alpha 2-adrenoceptor antagonists. Caroon JM; Clark RD; Kluge AF; Olah R; Repke DB; Unger SH; Michel AD; Whiting RL J Med Chem; 1982 Jun; 25(6):666-70. PubMed ID: 6124635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]